EVALUATION OF PATIENTS WITH CORONARY ARTERY DISEASE FOR MAJOR MODIFIABLE RISK FACTORS FOR ISCHEMIC HEART DISEASE

Authors

  • Mohammad Zahidullah
  • Muhammad Aasim
  • Ihsanullah Khan
  • Hamza Z Muhammadzai
  • Mumtaz Anwar Shah
  • Niaz Ali
  • Amir Mohammad
  • Azeem Muzahir
  • Muhammad Rehman

Abstract

Background: Incidence of cardiovascular diseases is on the rise in developing countries. Deaths due toischemic heart disease can be reduced by modifying the risk factors. The present study was conductedto evaluate the patients scheduled for Coronary Artery Bypass Surgery for the presence of majormodifiable risk factors for ischemic heart disease (IHD). Methods: It was a descriptive study. Allpatients who underwent elective Coronary Artery Bypass cardiac surgery between November 1, 2008and February 28, 2009 at Rehman Medical Institute, Peshawar, were included in the study. Presence ofDiabetes, Hypertension, Smoking, Dyslipidemia, Sedentary life style, and Obesity was looked for inthese patients. Results: A total of 104 patients were studied during this period. Majority (97.11%) ofpatients had at least one major modifiable risk factor for IHD. Sedentary life style (53.84%) was themost common risk factor present in these patients followed by hypertension and dyslipidemia (47.11%each), smoking (43.27%), diabetes (35.57%), and obesity (9.61%). Multiple risk factors (two or more)were found in 78 (75.0%) of patients. Conclusion: Most of the patients with coronary artery disease,severe enough to warrant coronary artery bypass grafting, have at least one of the major modifiable riskfactors for IHD. Modification of these factors may well reduce the disease burden of CAD and reducethe cardiovascular mortality.Keywords: Coronary Artery Bypass Surgery, Ischemic Heart Disease, Major Modifiable Risk Factors,Hypertension, Smoking, Diabetes, Dyslipidemia, Sedentary Life Style, Obesity

References

Murray CJL, Lopez AD, Eds. The global burden of disease: a

comprehensive assessment of mortality and disability from

diseases, injuries, and risk factors in 1990 and projected to 2020.

Boston: Harvard School of Public Health;1996.

J Ayub Med Coll Abbottabad 2012;24(2)

http://www.ayubmed.edu.pk/JAMC/24-2/Zahidullah.pdf 105

Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of

cardiovascular diseases, part I: general considerations, the

epidemiologic transition, risk factors, and impact of urbanization.

Circulation 2001;104:2746–53.

Gupta M, Singh N, Verma S. South Asians and cardiovascular

risk: what clinicians should know. Circulation 2006;113:924–9.

Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K et al. Risk

factors for early myocardial infarction in South Asians compared

with individuals in other countries. JAMA 2007;297:286–94.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray Cl.

Global and regional burden of disease and risk factors, 2001:

systematic analysis of population health data. Lancet

;367:1747–57.

Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener

SJ, et al. Prevelence of Conventional risk factors in Patients With

Coronary Heart Disease. JAMA 2003;290:898–904.

US Dept of Health and Human Services The Health Benefits of

Smoking cessation: A Report of the Surgeon General. Rockville,

Maryland: CDC; 1990. Available at:

http://profiles.nlm.nih.gov/ps/access/NNBBCT.pdf

Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other

risk factors, and 12-years cardiovascular mortality for men

screened in the Multiple Risk Factor Intervention trial. Diabetes

Care 1993;16:434–44.

Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D,

Menotti A, Aravanis C et al. Serum Total Cholestrol and Longterm coronary Heart Disease Mortality in Different Cultures.

JAMA 1995;274(2):131–36.

MacMahon S, Peto R, Collins R, Godwin J, MacMahon S, Cutlar

J, et al. Blood pressure, stroke, and coronary heart disease.

Lancet. 1990;335:765–774.

Moving into action: promoting heart-healthy and stroke-free

communities (health care leaders). Atlanta: center for disease

Control and Prevention, 2005.

Brown JR, O’Connor GT. Coronary Heart disease and Prevention

in the United States. N Engl J Med 2010;362: 2150–53.

Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow

GC, et al. AHA/ACC Guidelines for Secondary Prevention for

Patients With Coronary and Other Atherosclerotic Vascular

Disease: 2006 Update. J Am Coll Cardiol 2006;47:2130–9.

Hennekens CH. Increasing Burden of Cardiovascular Disease.

Current Knowledge and Future Direction for Research on Risk

Factors. Circulation. 1998;97:1095–102.

Futterman LG, LembergL. Fifty percent of patients with

coronary artery disease do not have any of the conventional risk

factors. Am J Crit Care 1998;7:240–4.

Department of Health. 2004. At Least Five a Week. Evidence on

the impact of physical activity and its relationship to health. A

report from the Chief Medical Officer. London: Department of

Health.

McPherson K, Britton A, Causer L. 2002. Monitoring on the

progress of the 2010 target for coronary heart disease mortality:

Estimated consequences on CHD incidence and mortality from

changing prevalence of risk factors. London: National Heart

Forum.

Physical Activity Guidelines Committee. Physical Activity

Guidelines Advisory Committee Report. Washington DC: Dept

of Health and Human Services; 2008.

Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F,

Roll S, Willich SN. Association of physical activity with allcause and cardiovascular mortality: a systematic review and

meta-analysis. Eur J Cardiovasc Prev Rehabil 2008;15:239–46.

Mora S, Cook N, Burning JE, Ridker PM, Lee IM. Physical

activity and reduced risk of cardiovascular events: potential

mediating mechanisms. Circulation 2007;116:2110–8.

Stamatakis E, Hamer M, Lawlor DA. Physical activity, mortality,

and cardiovascular disease: is domestic physical activity

beneficial? The Scottish Health Survey-1995, 1998, and 2003.

Ann J Epidemiol 2009;169:1191–200.

van Dam RM, List, Spiegelman D, Franco OH, Hu FB,.

Combined impact of lifestyle factors on mortality: prospective

cohort study in US women. BMJ 2008;337:1440.

Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ,

Kannel WB, et al. Impact of high-normal blood pressure on the

risk of cardiovascular disease. N Engl J Med

;345(18):1291–7.

Hyman DJ, Pavlik VN. Characteristics of patients with

uncontrolled hypertension in the United States. N Eng J Med

;345:479–86.

van den Hoogen PCW, Feskens EJM, Nagelkerke NJD, Menotti

A, Nissinen A, Kromhout D. The relation between blood

pressure and mortality due to coronary heart disease among men

in different parts of the world. N Engl J Med 2000;342:1–8.

Npolstad I, Arnesen E, Larsen PG. Smoking, serum lipids, blood

pressure and sex difference in myocardial infarction. Circulation

;93:450–6.

Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking

and risk of myocardial infarction in women and men:

longitudinal population study. BMJ 1998;316:1043–7.

US Dept of Health and Human Services. Reducing the Health

Consequences of Smoking: 25 years of Progress. A Report of the

Surgeon General. US Department of Health and Human

Services, Public Health Service, Centers for Disease Control,

Center for Chronic Disease Prevention and Health Promotion,

Office on Smoking and Health;1989. DHHS Publication (CDC)

-8411.

Anderson KM, Wilson PW, Odell PM, Kannel WD. An updated

coronary risk profile: a statement for health professionals.

Circulation 1991;83:356–62.

Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The

relationship of smoking cessation to coronary heart disease and

lung cancer in the Multiple Risk Factor Interventin Trial

(MRFIT). Am J Public Health 1990;80:954–58.

Elantz SA, Parmly WW. Passive smoking and heart disease.

Mechanisms and risk. JAMA 1995;273:1047.

Wells AJ. Passive smoking and heart disease. J AM Coll Cardiol

;24:546.

Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum

cholesterol concentration and coronary heart disease in

population with low cholesterol concentrations. BMJ

;303:276–82.

Eaton SB, Konner M, Shostak M. Stone agers in the fast lane:

chronic degenerative diseases in evolutionary perspective. Am J

Med 1988;84:739–49.

Arthaud JB. Cause of death in 339 Alaskan natives as determined

by autopsy. Arch Pathol 1970;90:433–8.

Howard BV, Rodriguez BL, Bennett PH, Harris MI, Hamman R,

Kuller RH, et al. Prevention Conference VI: Diabetes and

Cardiovascular disease: Writing Group I:

epidemiology. Circulation 2002;105:132–7.

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM,

Orchard TJ, et al. Intensive diabetes treatment and cardiovascular

disease in patients with type 1 diabetes. N Engl J Med

;353:2643–53.

Dluhy RG, McMahon GT. Intensive glycemic control in the

ACCORD and ADVANCE trials. N Engl J Med

;358:2630–3.

Holman RR, Paul SK, Bethel MA, H. Andrew W. Neil, David R.

Matthews. Long-term follow-up after tight control of blood

pressure in type 2 diabetes. N Engl J Med 2008;359:1565–76.

Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz

GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart

disease in women. JAMA 1998;280(21):1843–8.

World Health Organization. Obesity: preventing and managing

the global epidemic. Report of a WHO consultation on obesity.

Geneva: World Health Organization; 1998.

National Institutes of Health, National Heart, Lung, and Blood

Institute. Clinical guidelines on the identification, evaluation, and

treatment of overweight and obesity in adults: the evidence

report. Obes Res 1998;6:S51–210.

Allison DB, Zhu SK, Plankey M, Faith MS, Heo M. Differential

associations of body mass index and adiposity with all-cause

mortality among men in the first and second National Health and

Nutrition Examination Surveys (NHANES I and NHANES II)

follow-up studies. Int J Obes Relat Metab Disord 2002;26:410–6.

Published

2012-06-01